FIELD: pharmacology.
SUBSTANCE: application of a combination of the following four components of plant origin: milkwort root; astragalus root; lovage root; and Angelica Sinensis root, in the manufacture of a medicament for treatment of a disease or disorder selected from the group consisting of stroke, neurological disorder or ischemia, or for neuroconditioning for prophylactic induction of cerebral tolerance to an ischemic, epileptic or other damaging event. A kit for application in a method for treatment of a disease or disorder selected from the group consisting of stroke, neurological disorder or ischemia, or for neuroconditioning for prophylactic induction of cerebral tolerance to an ischemic, epileptic or other damaging event. A composition for use in treatment of a disease or disorder selected from the group consisting of stroke, neurologic disorder, ischemia, or for neuroconditioning to ensure brain tolerance to an ischemic, epileptic or other damaging event.
EFFECT: agents are effective for treatment of a disease or disorder selected from the group consisting of stroke, neurological disorder or ischemia, or for neuroconditioning for prophylactic induction of cerebral tolerance to an ischemic, epileptic or other damaging event.
22 cl, 6 dwg, 3 ex
